Latest Period
Q1 2026
Security Snapshot
IceCure Medical Ltd. - Ordinary Shares, no par value (ICCM) Institutional Ownership
CUSIP: M53071136
13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
3,249,330
Price
$0.30
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, no par value
- Symbol
- ICCM on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 3,249,330
- Total 13F value
- $976,776
- Portfolio coverage rank
- 0%
- Share change
- +2,724,527
- Value change
- +$751,816
- Number of holders
- 18
- Shares outstanding
- 78,267,679
- SEC-reported price per share
- $0.24
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ICCM - IceCure Medical Ltd. - Ordinary Shares, no par value is tracked under CUSIP M53071136.
- 18 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 19 to 18 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $318,670 to $976,776.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 18 institutions filings for Q1 2026.
Security key
M53071136
Latest holder period
Q1 2026
13F holders
18
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
ICCM full holder history
IceCure Medical Ltd. SEC filings
IceCure Medical Ltd. company facts
IceCure Medical Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP M53071136:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
ICCM
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Haixiang Li | 46% | +0.22% | $20,791,026 | +$5,800,000 | 35,846,597 | +39% | Mr. Li Haixiang | 17 Mar 2026 |
As of 31 Mar 2026, 18 institutional investors reported holding 3,249,330 shares of IceCure Medical Ltd. - Ordinary Shares, no par value (ICCM). This represents 4.2% of the company’s total 78,267,679 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
19
Latest
Q1 2026
Rows shown
1-19 of 19
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,249,330 | $976,776 | +$751,816 | $0.30 | 18 |
| 2025 Q4 | 524,803 | $318,670 | +$120,277 | $0.61 | 19 |
| 2025 Q3 | 293,952 | $297,190 | +$44,653 | $1.02 | 16 |
| 2025 Q2 | 249,665 | $247,019 | +$111,871 | $1.00 | 17 |
| 2025 Q1 | 129,931 | $152,798 | -$25,681 | $1.18 | 13 |
| 2024 Q4 | 153,141 | $167,705 | +$11,943 | $1.10 | 12 |
| 2024 Q3 | 194,284 | $117,866 | -$136,022 | $0.61 | 14 |
| 2024 Q2 | 361,028 | $267,533 | +$176,987 | $0.74 | 14 |
| 2024 Q1 | 100,498 | $120,094 | -$179,494 | $1.20 | 12 |
| 2023 Q4 | 268,137 | $290,607 | +$75,177 | $1.07 | 15 |
| 2023 Q3 | 232,538 | $127,536 | +$2,901 | $0.54 | 11 |
| 2023 Q2 | 155,395 | $180,324 | +$93,065 | $1.16 | 10 |
| 2023 Q1 | 75,937 | $87,537 | -$90,529 | $1.15 | 6 |
| 2022 Q4 | 158,151 | $244,966 | +$143,970 | $1.55 | 9 |
| 2022 Q3 | 65,291 | $84,309 | -$66,120 | $1.29 | 6 |
| 2022 Q2 | 63,859 | $174,427 | +$42,045 | $1.70 | 8 |
| 2022 Q1 | 71,148 | $171,607 | -$2,106,694 | $2.43 | 9 |
| 2021 Q4 | 764,988 | $2,313,000 | +$1,159,901 | $3.02 | 12 |
| 2021 Q3 | 382,011 | $3,338,000 | +$3,338,000 | $8.83 | 7 |